Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016–2018)
暂无分享,去创建一个
H. Goossens | P. van Damme | H. Theeten | P. Beutels | S. Malhotra-Kumar | D. Martiny | G. Serrano | M. Wautier | A. Deplano | K. Maertens | L. Willen | L. Van Heirstraeten | Esra Ekinci | Juan Pablo Rodriguez Ruiz
[1] B. Bozdoğan,et al. Use of trans-complementation method to determine the effects of various ftsI mutations on β-lactamase-negative ampicillin-resistant (BLNAR) Haemophilus influenzae strains , 2022, Archives of Microbiology.
[2] H. Goossens,et al. Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV , 2022, Journal of the Pediatric Infectious Diseases Society.
[3] R. Drew,et al. Haemophilus influenzae type f in the post-Haemophilus influenzae type b vaccination era: a systematic review. , 2022, Journal of medical microbiology.
[4] M. Ulanova,et al. Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use , 2021, Clinical microbiology reviews.
[5] H. Claus,et al. Cefotaxime resistance in invasive Haemophilus influenzae isolates in Germany 2016-19: prevalence, epidemiology and relevance of PBP3 substitutions. , 2021, Journal of Antimicrobial Chemotherapy.
[6] N. Ahmad,et al. Carriage of Haemophilus influenzae among children attending childcare centres in Kuala Lumpur, Malaysia in the post vaccination era: A cross-sectional study. , 2020, Vaccine.
[7] R. Cunney,et al. Epidemiology of Haemophilus influenzae in the Republic of Ireland, 2010–2018 , 2020, European Journal of Clinical Microbiology & Infectious Diseases.
[8] W. Schaffner,et al. Epidemiology of Invasive Haemophilus influenzae Serotype a Disease-United States, 2008-2017. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] E. Tanaka,et al. Emergence of Haemophilus influenzae with low susceptibility to quinolones and persistence in tosufloxacin treatment. , 2019, Journal of global antimicrobial resistance.
[10] Hong Zhang,et al. Antibiotic Resistance Profiles of Haemophilus influenzae Isolates from Children in 2016: A Multicenter Study in China , 2019, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.
[11] K. Jolley,et al. High diversity of invasive Haemophilus influenzae isolates in France and the emergence of resistance to third generation cephalosporins by alteration of ftsI gene. , 2019, The Journal of infection.
[12] E. Choi,et al. Increasing Prevalence of Group III Penicillin-Binding Protein 3 Mutations Conferring High-Level Resistance to Beta-Lactams Among Nontypeable Haemophilus influenzae Isolates from Children in Korea. , 2019, Microbial drug resistance.
[13] Lise Schotte,et al. Detection of beta-lactamase-negative ampicillin resistance in Haemophilus influenzae in Belgium. , 2019, Diagnostic microbiology and infectious disease.
[14] Hiroki Takahashi,et al. Multiclonal Expansion and High Prevalence of β-Lactamase-Negative Haemophilus influenzae with High-Level Ampicillin Resistance in Japan and Susceptibility to Quinolones , 2018, Antimicrobial Agents and Chemotherapy.
[15] H. Goossens,et al. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme. , 2018, Vaccine.
[16] F. Ruiz-López,et al. Epidemiology of Nasopharyngeal Carriage by Haemophilus influenzae in Healthy Children: A Study in the Mediterranean Coast Region , 2017, The Pediatric infectious disease journal.
[17] M. Ulanova,et al. The changing epidemiology of invasive Haemophilus influenzae disease: Emergence and global presence of serotype a strains that may require a new vaccine for control. , 2017, Vaccine.
[18] M. Slack. The evidence for non-typeable Haemophilus influenzae as a causative agent of childhood pneumonia , 2017, Pneumonia.
[19] D. Kunde,et al. Effect of epithelial cell type on in vitro invasion of non-typeable Haemophilus influenzae. , 2016, Journal of microbiological methods.
[20] E. Redwan,et al. Hib Vaccines: Past, Present, and Future Perspectives , 2016, Journal of immunology research.
[21] S. Ladhani,et al. Non-typeable Haemophilus influenzae, an under-recognised pathogen. , 2014, The Lancet. Infectious diseases.
[22] G. Zosky,et al. Genotypically defined β-lactamase-negative ampicillin-resistant isolates of non-typable Haemophilus influenzae are associated with increased invasion of bronchial epithelial cells in vitro. , 2014, Journal of medical microbiology.
[23] A. Sundsfjord,et al. Multilocus sequence typing and ftsI sequencing: a powerful tool for surveillance of penicillin-binding protein 3-mediated beta-lactam resistance in nontypeable Haemophilus influenzae , 2014, BMC Microbiology.
[24] S. Ladhani,et al. Invasive Haemophilus influenzae Serotype e and f Disease, England and Wales , 2012, Emerging infectious diseases.
[25] T. Murphy,et al. Haemophilus influenzae Infections in the H. influenzae Type b Conjugate Vaccine Era , 2011, Journal of Clinical Microbiology.
[26] M. Cerquetti,et al. Polymorphism in ftsI gene and {beta}-lactam susceptibility in Portuguese Haemophilus influenzae strains: clonal dissemination of beta-lactamase-positive isolates with decreased susceptibility to amoxicillin/clavulanic acid. , 2011, The Journal of antimicrobial chemotherapy.
[27] E. Kasuga,et al. An amino acid substitution in PBP-3 in Haemophilus influenzae associate with the invasion to bronchial epithelial cells. , 2010, Microbiological research.
[28] Hideaki Suzuki,et al. Nasopharyngeal Haemophilus influenzae Carriage in Japanese Children Attending Day-Care Centers , 2008, Journal of Clinical Microbiology.
[29] N. Yamanaka,et al. Genetic Characteristics and Clonal Dissemination of β-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae Strains Isolated from the Upper Respiratory Tract of Patients in Japan , 2007, Antimicrobial Agents and Chemotherapy.
[30] J. Campos,et al. Ampicillin-Resistant Non-β-Lactamase-Producing Haemophilus influenzae in Spain: Recent Emergence of Clonal Isolates with Increased Resistance to Cefotaxime and Cefixime , 2007, Antimicrobial Agents and Chemotherapy.
[31] G. Swingler,et al. Conjugate vaccines for preventing Haemophilus influenzae type B infections. , 2007, The Cochrane database of systematic reviews.
[32] S. Awasthi,et al. High ampicillin resistance in different biotypes and serotypes of Haemophilus influenzae colonizing the nasopharynx of healthy school-going Indian children. , 2006, Journal of medical microbiology.
[33] Sabine Mérienne,et al. Programme , 1953, Neuromuscular Disorders.
[34] K. Sunakawa,et al. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. , 2003, Microbial drug resistance.
[35] K. Sunakawa,et al. Differentiation of β-lactamase-negative ampicillin-resistant Haemophilus influenzae from other H. influenzae strains by a disc method , 2002, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[36] K. Yamamoto,et al. Association of Amino Acid Substitutions in Penicillin-Binding Protein 3 with β-Lactam Resistance in β-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae , 2001, Antimicrobial Agents and Chemotherapy.
[37] H. Peltola. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. , 2000, Clinical microbiology reviews.
[38] D. Madore. Impact of immunization on Haemophilus influenzae type b disease. , 1996, Infectious agents and disease.
[39] C. Svanborg,et al. Nasopharyngeal colonization during the first year of life. , 1992, The Journal of infectious diseases.
[40] J. Righter,et al. Haemophilus influenzae from four laboratories in one Canadian city. , 1988, The Journal of antimicrobial chemotherapy.
[41] K C Watson,et al. Temporal changes in biotypes of Haemophilus influenzae isolated from patients with cystic fibrosis. , 1988, Journal of medical microbiology.
[42] J. Musser,et al. Genetic and phenotypic diversity among ampicillin-resistant, non-beta-lactamase-producing, nontypeable Haemophilus influenzae isolates , 1987, Infection and immunity.
[43] G. Jacoby,et al. An animal source for the ROB-1 beta-lactamase of Haemophilus influenzae type b , 1986, Antimicrobial Agents and Chemotherapy.
[44] P. Gilligan,et al. Biotype of Haemophilus influenzae: correlation with virulence and ampicillin resistance. , 1983, The Journal of infectious diseases.
[45] B. Mittelman,et al. On control. , 1979, Dental management.
[46] J. Brunton,et al. Biochemical characteristics of Haemophilus influenzae in relationship to source of isolation and antibiotic resistance , 1978, Journal of clinical microbiology.
[47] P. Mäkelä,et al. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. , 1977, Pediatrics.
[48] M. Kilian. A taxonomic study of the genus Haemophilus, with the proposal of a new species. , 1976, Journal of general microbiology.
[49] M. Pittman. VARIATION AND TYPE SPECIFICITY IN THE BACTERIAL SPECIES HEMOPHILUS INFLUENZAE , 1931, The Journal of experimental medicine.